Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gout drug may halt dangerous seizure clusters in epilepsy patients

NCT ID NCT07318870

First seen Jan 11, 2026 · Last updated May 18, 2026 · Updated 21 times

Summary

This study tests whether probenecid, a medicine used for gout, can stop clusters of seizures in people with focal epilepsy. Participants will be in the hospital for video-EEG monitoring while their usual seizure medicines are reduced. The goal is to see if a single dose of probenecid can prevent further seizures for 12 hours.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FOCAL EPILEPSY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.